Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 8-K Event Material agreement · Agreement ended
  8. 424B5 Offering Prospectus
  9. SCHEDULE 13D/A Stake Beneficial Ownership Report
  10. 4 Insider Changes in Ownership
  11. EFFECT Other Notice of Effectiveness
  12. S-3/A Offering Registration Statement
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 1 of 21 · 412 filings